STK11 and metabolic dysfunction-associated steatotic liver disease: Therefore, this study aimed to address the specific question: Does HLWDD ameliorate NAFLD through modulation of the gut-liver axis (specifically Akkermansia-dependent aspartate metabolism) and activation of the LKB1/AMPK pathway?